RDY logo

Dr. Reddy's Laboratories Limited (RDY)

Profile

Full Name

Dr. Reddy's Laboratories Limited

Ticker

NYSE: RDY

Exchange

NYSE

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

India

IPO

April 11, 2001

Indexes

Not included

Website

http://www.drreddys.com

Employees

27811

Key Details

Price

$14.67(-0.27%)

Market cap

Last Dividend

$0.09

TTM Dividend yield

1.28%

Annual revenue

$3.85B(+14.19% YoY)

Annual EPS

$0.80(-0.64% YoY)

PE ratio

22.37

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $14.67
    RDY price is $14.67

    30-Day Relative Volume

    0.75
    RDY 30-day relative volume is 0.75

    Price Performance

    Price Most recent change

    -0.27%
    RDY price was down -0.27% on Jul 25, 2025

    Price YTD change

    -7.09%
    RDY price is down -7.09% since January 1st

    Price 1-year change

    -9.27%
    RDY price is down -9.27% year-on-year

    Price 3-year change

    +35.23%
    RDY price is up +35.23% over the past 3 years

    Price Range

    Price All-time high

    $84.46
    RDY price is currently -82.63% below its historical high of $84.46

    Price 3-year low

    $9.98
    RDY price is currently +46.99% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $12.21B
    RDY market capitalization is $12.21 billion

    Market cap 3-year change

    +35.63%
    RDY market capitalization is up +35.63% over the past 3 years

    Market cap All-time high

    $14.03B
    RDY market capitalization is currently -12.95% below its historical high of $14.03 billion

    Market cap sector rank

    93.24%
    RDY market capitalization is higher than 93.24% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.04%
    RDY shares outstanding is down -0.04% year-on-year

    Shares Outstanding 3-Year Change

    +0.3%
    RDY shares outstanding is up +0.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.49
    RDY beta is 0.49

    200-day SMA

    $14.38
    RDY price is currently +2.02% above its 200-day simple moving average

    50-day SMA

    $14.92
    RDY price is currently -1.68% below its 50-day simple moving average

    RSI

    46.92
    RDY 14-day relative strength index is 46.92

    Volume

    0.75
    RDY 30-day relative volume is 0.75

    ATR

    $0.24
    RDY average true range is $0.24

    10-day Historical Volatility

    13.19%
    RDY 10-day historical volatility is 13.19%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.09
    RDY last dividend was $0.09 per share, with an ex-dividend date of July 25, 2025

    Next Dividend

    -
    RDY next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.10
    RDY annual dividend per share is $0.10

    Dividend per share Sector Rank

    4.71%
    RDY annual dividend per share is higher than 4.71% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -1.35%
    RDY annual dividend per share is down -1.35% year-on-year

    Dividend per share 3-Year Change

    +42.73%
    RDY annual dividend per share is up +42.73% over the past 3 years

    Dividend yield

    Dividend yield

    0.65%
    RDY annual dividend yield is 0.65%

    Dividend yield Sector Rank

    20.24%
    RDY annual dividend yield is higher than 20.24% of companies in Healthcare sector

    Other

    Payout ratio

    11.78%
    RDY annual payout ratio is 11.78%

    Dividends paid

    $78.80M
    RDY annual dividends paid is $78.80 million

    Free cash flow

    $142.30M
    RDY annual free cash flow is $142.30 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.85B
    RDY annual revenue is $3.85 billion

    Revenue Analysts estimate

    $344.08B
    RDY annual revenue is currently -98.88% lower than the consensus analysts' forecast

    Revenue 1-year change

    +14.19%
    RDY annual revenue is up +14.19% year-on-year

    Revenue Sector rank

    89.94%
    RDY annual revenue is higher than 89.94% of companies in Healthcare sector

    EPS

    EPS

    $0.80
    RDY annual earnings per share is $0.80

    EPS Analysts estimate

    $68.43
    RDY annual earnings per share is currently -98.83% lower than the consensus analysts' forecast

    EPS 1-year change

    -0.64%
    RDY annual earnings per share is down -0.64% year-on-year

    EPS Sector rank

    88.38%
    RDY annual earnings per share is higher than 88.38% of companies in Healthcare sector

    Profit

    Gross profit

    $2.67B
    RDY annual gross profit is $2.67 billion

    Gross margin

    69.34%
    RDY annual gross profit margin is 69.34%

    Operating profit

    $829.51M
    RDY annual operating income is $829.51 million

    Operating margin

    21.54%
    RDY annual operating profit margin is 21.54%

    Net income

    $668.84M
    RDY annual net profit is $668.84 million

    Net margin

    17.37%
    RDY annual net profit margin is 17.37%

    Expenses

    Total expenses

    $3.02B
    RDY annual total expenses is $3.02 billion

    Operating expenses

    $1.84B
    RDY annual total operating expenses is $1.84 billion

    Cost of goods sold

    $1.18B
    RDY annual cost of goods sold is $1.18 billion

    Selling, general & administrative expenses

    $1.65B
    RDY annual SGA is $1.65 billion

    Depreciation and amortization

    $201.52M
    RDY annual depreciation & amortization is $201.52 million

    Interest expense

    $33.46M
    RDY annual interest expense is $33.46 million

    Income tax

    $231.17M
    RDY annual income tax is $231.17 million

    EBIT & EBITDA

    EBIT

    $941.84M
    RDY annual earnings before interest & taxes is $941.84 million

    EBITDA

    $1.14B
    RDY annual EBITDA is $1.14 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.76B
    RDY annual total assets is $5.76 billion

    Non current assets

    $2.85B
    RDY annual long term assets is $2.85 billion

    Current assets

    $2.92B
    RDY annual total current assets is $2.92 billion

    Cash and cash equivalents

    $171.32M
    RDY annual cash & cash equivalents is $171.32 million

    Accounts receivable

    $1.06B
    RDY annual accounts receivable is $1.06 billion

    Inventory

    $831.05M
    RDY annual inventory is $831.05 million

    Liabilities

    Total liabilities

    $1.82B
    RDY annual total liabilities is $1.82 billion

    Long term liabilities

    $288.23M
    RDY annual total long term liabilities is $288.23 million

    Current liabilities

    $1.52B
    RDY annual total current liabilities is $1.52 billion

    Accounts payable

    $234.44M
    RDY annual accounts payable is $234.44 million

    Debt

    Total debt

    $546.74M
    RDY annual total debt is $546.74 million

    Total debt 1-year change

    +127.75%
    RDY annual total debt is up +127.75% year-on-year

    Long term debt

    $91.94M
    RDY annual long term debt is $91.94 million

    Short term debt

    $454.80M
    RDY annual short term debt is $454.80 million

    Equity & Capital

    Shareholders equity

    $3.90B
    RDY annual stockholders equity is $3.90 billion

    Book value

    $3.92B
    RDY annual book value is $3.92 billion

    Retained earnings

    $3.69B
    RDY annual retained earnings is $3.69 billion

    Working capital

    $1.40B
    RDY annual working capital is $1.40 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $549.18M
    RDY annual cash flow from operations is $549.18 million

    Cash from operations 1-year change

    +0.07%
    RDY annual cash flow from operations is up +0.07% year-on-year

    Cash from investing

    -$603.51M
    RDY annual cash flow from investing activities is -$603.51 million

    Cash from investing 1-year change

    -24.02%
    RDY annual cash flow from investing activities is down -24.02% year-on-year

    Cash from financing

    $140.23M
    RDY annual cash flow from financing activities is $140.23 million

    Cash from financing 1-year change

    +408.49%
    RDY annual cash flow from financing activities is up +408.49% year-on-year

    CAPEX

    CAPEX

    $406.88M
    RDY annual capital expenditures is $406.88 million

    CAPEX 1-year change

    +22.77%
    RDY annual capital expenditures is up +22.77% year-on-year

    Free Cash Flow

    Free cash flow

    $142.30M
    RDY annual free cash flow is $142.30 million

    Free cash flow 1-year change

    -34.55%
    RDY annual free cash flow is down -34.55% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.34%
    RDY annual gross profit margin is 69.34%

    Operating margin

    21.54%
    RDY annual operating profit margin is 21.54%

    Net margin

    17.37%
    RDY annual net profit margin is 17.37%

    ROA & ROE

    ROA

    12.85%
    RDY annual return on assets is 12.85%

    ROE

    18.31%
    RDY annual return on equity is 18.31%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    22.37
    RDY price to earnings ratio is 22.37

    PE ratio Sector rank

    45.75%
    RDY price to earnings ratio is higher than 45.75% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.98
    RDY price to book ratio is 2.98

    PB ratio Sector rank

    65.84%
    RDY price to book ratio is higher than 65.84% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.11
    RDY price to sales ratio is 3.11

    PS ratio Sector rank

    49.87%
    RDY price to sales ratio is higher than 49.87% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $12.67B
    RDY enterprise value is $12.67 billion

    Enterprise value Sector rank

    93.24%
    RDY enterprise value is higher than 93.24% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    11.00
    RDY EV/EBITDA is 11.00

    EV/EBITDA Sector rank

    84.42%
    RDY EV/EBITDA is higher than 84.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.92
    RDY annual current ratio is 1.92

    Quick ratio

    1.37
    RDY annual quick ratio is 1.37

    Leverage

    Debt to equity

    0.12
    RDY annual debt to equity ratio is 0.12

    Interest coverage ratio

    28.15
    RDY annual interest coverage ratio is 28.15

    Risk & Stability

    Piotroski F-Score

    -
    RDY piotroski f-score value is unknown

    Altman Z-Score

    6.42
    RDY altman z-score is 6.42

    Analyst ratings

    Recent major analysts updates

    Jun 5, 25 HSBC
    Buy
    Nov 6, 24 Barclays
    Overweight
    Jul 30, 24 Barclays
    Overweight
    May 8, 24 Barclays
    Overweight
    Jan 29, 24 Barclays
    Overweight
    Jun 1, 23 Barclays
    Overweight
    Oct 31, 22 Barclays
    Overweight
    Oct 25, 22 Barclays
    Overweight
    Sep 12, 22 Barclays
    Overweight
    Jul 25, 22 Barclays
    Overweight

    Institutional Ownership

    Screeners with RDY included

    Best performing stocks last 5 years
    Stocks above SMA 50
    Healthcare sector
    Companies with growing dividends
    All stocks
    High Altman Z score stocks
    Most aggressive growth stocks
    Companies with buyback
    Earnings this week
    Best performing stocks last 15 years
    • What is the ticker symbol for Dr. Reddy's Laboratories Limited?
    • Does Dr. Reddy's Laboratories Limited pay dividends?
    • What sector is Dr. Reddy's Laboratories Limited in?
    • What industry is Dr. Reddy's Laboratories Limited in?
    • What country is Dr. Reddy's Laboratories Limited based in?
    • When did Dr. Reddy's Laboratories Limited go public?
    • Is Dr. Reddy's Laboratories Limited in the S&P 500?
    • Is Dr. Reddy's Laboratories Limited in the NASDAQ 100?
    • Is Dr. Reddy's Laboratories Limited in the Dow Jones?
    • When was Dr. Reddy's Laboratories Limited's last earnings report?
    • When does Dr. Reddy's Laboratories Limited report earnings?

    What is the ticker symbol for Dr. Reddy's Laboratories Limited?

    The ticker symbol for Dr. Reddy's Laboratories Limited is NYSE:RDY

    Does Dr. Reddy's Laboratories Limited pay dividends?

    Yes, Dr. Reddy's Laboratories Limited pays dividends. The last payment was $0.09, with an ex-dividend date on July 25, 2025

    What sector is Dr. Reddy's Laboratories Limited in?

    Dr. Reddy's Laboratories Limited is in the Healthcare sector

    What industry is Dr. Reddy's Laboratories Limited in?

    Dr. Reddy's Laboratories Limited is in the Specialty & Generic Drug Manufacturers industry

    What country is Dr. Reddy's Laboratories Limited based in?

    Dr. Reddy's Laboratories Limited is headquartered in India

    When did Dr. Reddy's Laboratories Limited go public?

    Dr. Reddy's Laboratories Limited's initial public offering (IPO) was on April 11, 2001

    Is Dr. Reddy's Laboratories Limited in the S&P 500?

    No, Dr. Reddy's Laboratories Limited is not included in the S&P 500 index

    Is Dr. Reddy's Laboratories Limited in the NASDAQ 100?

    No, Dr. Reddy's Laboratories Limited is not included in the NASDAQ 100 index

    Is Dr. Reddy's Laboratories Limited in the Dow Jones?

    No, Dr. Reddy's Laboratories Limited is not included in the Dow Jones index

    When was Dr. Reddy's Laboratories Limited's last earnings report?

    Dr. Reddy's Laboratories Limited's most recent earnings report was on July 23, 2025

    When does Dr. Reddy's Laboratories Limited report earnings?

    The next expected earnings date for Dr. Reddy's Laboratories Limited is November 5, 2025
    On this page